Clinical Trial Update: Micro RNA Genetic Signature in NSCLC Egyptian Patients

View source ↗

Summary

A clinical trial evaluating microRNA genetic signatures in Egyptian patients with non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Adel Salah Bediwy | Conditions: Non-small Cell Lung Cancer | Status: COMPLETED